BioMarin Pharmaceutical Inc. 7,500,000 Shares Common Stock ($0.001 par value) UNDERWRITING AGREEMENTUnderwriting Agreement • February 21st, 2003 • Biomarin Pharmaceutical Inc • Pharmaceutical preparations • New York
BioMarin Pharmaceutical Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the Underwriters named in Schedule A annexed hereto (the “Underwriters”) an aggregate of 7,500,000 shares of Common Stock, $0.001 par value per share (the “Common Stock”), of the Company (the “Firm Shares”). In addition, solely for the purpose of covering over-allotments, the Company proposes to grant to the Underwriters the option to purchase from the Company up to an additional 1,125,000 shares of Common Stock (the “Additional Shares”). The Firm Shares and the Additional Shares are hereinafter collectively sometimes referred to as the Shares. The Shares are described in the Prospectus which is referred to below.
